|
Published by: Kalorama Information
Published: Apr. 1, 2001 - 357 Pages Special Offer: Now 25%
off original sale price of $3750
Table of Contents
Chapter One
Executive Summary
- Introduction
- Scope And Methodology
- Size And Growth Of Market
- Market Trends
- The Nature Of The Industry
- The Applications
- Cancer
- Rheumatoid Arthritis
- Hiv/Aids
- Autoimmune Diseases
- Allergy And Asthma
- Vaccines
Chapter Two
Introduction
- Background
- Defining Immunotherapy
- The Pros And Cons Of Immunotherapy
- Point Of View
Chapter Three
Cancer Immunotherapy
- Epidemiology
- Market Population Trends
- Cancer Prevalence Trends
- Cancer Incidence Trends
- Immunological And Vaccine Approaches
- Market Overview
- Immunotherapy Background
- The Technological Basis For Cancer Immunotherapy
- Cytokine Therapeutics
- Genetic Cytokine Stimulation
- Cancer Vaccines
- Modified Antibodies
- Alternative Approaches To Cancer Immunotherapy
- Progress In Cancer Immunotherapy
- Limitations Of Immune Therapy
- The Commercial Outlook
Chapter Four
Rheumatoid Arthritis
- Background And Epidemiology
- Market Overview
- Immunotherapy Approaches
- Commercial Outlook
Chapter Five
Hiv/Aids
- Background And Epidemiology
- Market Overview
- Immunotherapy Approaches
- Commercial Outlook
Chapter Six
Autoimmune Diseases
- Background And Epidemiology
- Multiple Sclerosis Myasthenia Gravis
- Scleroderma
- Systemic Lupus Erythematosus
- Market Overview
- Immunotherapy Approaches
- Commercial Outlook
Chapter Seven
Allergy And Asthma
- Background And Epidemiology
- Market Overview
- Immunotherapy Approaches
- Commercial Outlook
Chapter Eight
Vaccines
- Background And Epidemiology
- Market Overview
- Immunotherapy Approaches
- Commercial Outlook
Chapter Nine
Company Profiles
- Abgenix, Inc.
- Amgen, Inc.
- Argonex, Inc.
- Autoimmune, Inc.
- Biogen, Inc.
- Biomira, Inc.
- Centocor (Johnson & Johnson)
- Corixa Corp.
- Cypress Bioscience, Inc.
- Genzyme Molecular Oncology
- Igeneon Gmbh
- Immunex, Inc.
- Morphosys Ag
- Vasogen, Inc.
- Vertex Pharmaceuticals, Inc.
- Vical, Inc.
Chapter Ten
Conclusions And Strategic Implications
Appendix A
Glossary
Appendix B
Company Names And Addresses
AbstractBeyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known.
This report from MarketResearch.com examines this market and provides forecasts to 2005 for major immunotherapy products including:
- Corticosteroids
- Cyclosporin and Related Immunosuppresives
- NSAIDS
- Gamma Globulins
- Monoclonal Antibodies
- Cytokines/Lymphokines
- Immunizations and vaccines
In addition, the use of Genetic Manipulation for immunomodulation will be discussed in detail.
The report will present and detail advanced research efforts.
Commercial efforts and strategic alliances will be clearly presented for the specific companies profiled in the report.
Get Full Details About This Report >>
|
